There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Molina Healthcare (MOH – Research Report), Dexcom (DXCM – Research Report) and Tenaya Therapeutics (TNYA – Research Report) with bullish sentiments.
Molina Healthcare (MOH)
In a report issued on February 8, Ann Hynes from Mizuho Securities maintained a Buy rating on Molina Healthcare, with a price target of $415.00. The company’s shares closed last Monday at $392.63, close to its 52-week high of $393.34.
According to TipRanks.com, Hynes is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Molina Healthcare with a $402.78 average price target, a 3.5% upside from current levels. In a report issued on February 8, Cantor Fitzgerald also maintained a Buy rating on the stock with a $406.00 price target.
See today’s best-performing stocks on TipRanks >>
Dexcom (DXCM)
In a report issued on February 8, Jeff Johnson from Robert W. Baird maintained a Buy rating on Dexcom, with a price target of $161.00. The company’s shares closed last Monday at $118.42.
According to TipRanks.com, Johnson is a 5-star analyst with an average return of
Currently, the analyst consensus on Dexcom is a Strong Buy with an average price target of $146.92, implying a 22.9% upside from current levels. In a report issued on January 26, Wells Fargo also maintained a Buy rating on the stock with a $145.00 price target.
Tenaya Therapeutics (TNYA)
In a report issued on February 8, Mani Foroohar from Leerink Partners reiterated a Buy rating on Tenaya Therapeutics, with a price target of $7.00. The company’s shares closed last Monday at $5.66.
According to TipRanks.com, Foroohar is a 2-star analyst with an average return of
Tenaya Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $7.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on MOH:
